AVEO - AVEO Pharmaceuticals GAAP EPS of -$0.09 beats by $0.08 revenue of $30.4M beats by $0.54M
- AVEO Pharmaceuticals press release ( NASDAQ: AVEO ): Q3 GAAP EPS of -$0.09 beats by $0.08 .
- Revenue of $30.4M (+100.4% Y/Y) beats by $0.54M .
- At September 30, 2022, AVEO reported $77.4 million in cash, cash equivalents and marketable securities, as compared with $77.2 million at the end of June 30, 2022 and $87.3 million at December 31, 2021.
For further details see:
AVEO Pharmaceuticals GAAP EPS of -$0.09 beats by $0.08, revenue of $30.4M beats by $0.54M